Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)
Background: Chronic kidney disease-associated pruritus (CKD-aP) affects patients on hemodialysis. This study identified hemodialysis patients presumably affected or not affected by CKD-aP and integrated healthcare costs, from the perspective of the Italian administrative healthcare data. Methods: Through cross-linkage of Italian administrative healthcare data collected between 2015 and 2017 (accrual period) in the database of Fondazione ReS (Ricerca e Salute), patients undergoing in-hospital/outpatient hemodialysis were selected. Cohorts with and without CKD-aP were created based on the presence/absence of CKD-aP-related treatment (according to common clinical practice and guidelines) supplies and assessed in terms of CKD-aP-related treatments and mean healthcare costs per capita paid by the Italian National Health Service (INHS). Results: Of 1,239 people on hemodialysis for ≥2 years, CKD-aP affected 218 patients. Patients with CKD-aP were older and with more comorbidities. During the follow-up year, on average, the INHS spent €37,065 per case, €31,286 per control and € 35,988 per non-CKD-aP subject. High-efficiency dialytic therapies performed to people on hemodialysis with CKD-aP largely weighed on the overall mean annual cost. Conclusions: This real-world study identified patients on chronic hemodialysis potentially treated for CKD-aP. Interestingly, high-efficiency dialysis seems the most frequent and expensive choice for the treatment of CKD-aP. The discovery of appropriate and effective treatments for this condition might offer cost offsets..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Global & Regional Health Technology Assessment - 11(2024), 1 |
| Sprache: |
Englisch ; Spanisch ; Italienisch |
|---|
| Beteiligte Personen: |
Silvia Calabria [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Costs |
|---|
| doi: |
10.33393/grhta.2024.2696 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ097595284 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ097595284 | ||
| 003 | DE-627 | ||
| 005 | 20240413190031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.33393/grhta.2024.2696 |2 doi | |
| 035 | |a (DE-627)DOAJ097595284 | ||
| 035 | |a (DE-599)DOAJ55dd389b686847d8a7f3eeda7a76c083 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a ita | ||
| 050 | 0 | |a R855-855.5 | |
| 100 | 0 | |a Silvia Calabria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: Chronic kidney disease-associated pruritus (CKD-aP) affects patients on hemodialysis. This study identified hemodialysis patients presumably affected or not affected by CKD-aP and integrated healthcare costs, from the perspective of the Italian administrative healthcare data. Methods: Through cross-linkage of Italian administrative healthcare data collected between 2015 and 2017 (accrual period) in the database of Fondazione ReS (Ricerca e Salute), patients undergoing in-hospital/outpatient hemodialysis were selected. Cohorts with and without CKD-aP were created based on the presence/absence of CKD-aP-related treatment (according to common clinical practice and guidelines) supplies and assessed in terms of CKD-aP-related treatments and mean healthcare costs per capita paid by the Italian National Health Service (INHS). Results: Of 1,239 people on hemodialysis for ≥2 years, CKD-aP affected 218 patients. Patients with CKD-aP were older and with more comorbidities. During the follow-up year, on average, the INHS spent €37,065 per case, €31,286 per control and € 35,988 per non-CKD-aP subject. High-efficiency dialytic therapies performed to people on hemodialysis with CKD-aP largely weighed on the overall mean annual cost. Conclusions: This real-world study identified patients on chronic hemodialysis potentially treated for CKD-aP. Interestingly, high-efficiency dialysis seems the most frequent and expensive choice for the treatment of CKD-aP. The discovery of appropriate and effective treatments for this condition might offer cost offsets. | ||
| 650 | 4 | |a Costs | |
| 650 | 4 | |a Dialysis | |
| 650 | 4 | |a End-stage kidney disease | |
| 650 | 4 | |a Italy | |
| 650 | 4 | |a Retrospective analysis | |
| 650 | 4 | |a RWE | |
| 653 | 0 | |a Medical technology | |
| 700 | 0 | |a Manenti Lucio |e verfasserin |4 aut | |
| 700 | 0 | |a Giulia Ronconi |e verfasserin |4 aut | |
| 700 | 0 | |a Carlo Piccinni |e verfasserin |4 aut | |
| 700 | 0 | |a Leonardo Dondi |e verfasserin |4 aut | |
| 700 | 0 | |a Letizia Dondi |e verfasserin |4 aut | |
| 700 | 0 | |a Antonella Pedrini |e verfasserin |4 aut | |
| 700 | 0 | |a Immacolata Esposito |e verfasserin |4 aut | |
| 700 | 0 | |a Alice Addesi |e verfasserin |4 aut | |
| 700 | 0 | |a Filippo Aucella |e verfasserin |4 aut | |
| 700 | 0 | |a Nello Martini |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Global & Regional Health Technology Assessment |d AboutScience Srl, 2017 |g 11(2024), 1 |w (DE-627)DOAJ000020729 |x 22835733 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2024 |g number:1 |
| 856 | 4 | 0 | |u https://doi.org/10.33393/grhta.2024.2696 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/55dd389b686847d8a7f3eeda7a76c083 |z kostenfrei |
| 856 | 4 | 0 | |u https://journals.aboutscience.eu/index.php/grhta/article/view/2696 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2284-2403 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2283-5733 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2024 |e 1 | ||